These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 10632320

  • 21. Elevated preoperative serum ICTP is a prognostic factor for overall and disease-free survival in breast cancer.
    Keskikuru R, Bloigu R, Risteli J, Kataja V, Jukkola A.
    Oncol Rep; 2002; 9(6):1323-7. PubMed ID: 12375042
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Total procollagen type 1 amino-terminal propeptide (total P1NP) as a bone metastasis marker in gynecological carcinomas.
    Oremek G, Sauer-Eppel H, Klepzig M.
    Anticancer Res; 2007; 27(4A):1961-2. PubMed ID: 17649805
    [Abstract] [Full Text] [Related]

  • 24. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism.
    Papadopoulou E, Anagnostopoulos K, Tripsianis G, Tentes I, Kakolyris S, Galazios G, Sivridis E, Simopoulos K, Kortsaris A.
    Neoplasma; 2008; 55(3):229-38. PubMed ID: 18348656
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Serum ostase in the follow-up of breast cancer patients.
    Marchei P, Santini D, Bianco V, Chiodini S, Reale MG, Simeoni F, Marchei GG, Vecchione A.
    Anticancer Res; 1995; 15(5B):2217-22. PubMed ID: 8572628
    [Abstract] [Full Text] [Related]

  • 28. Serum bone sialoprotein levels and bone metastases.
    Uccello M, Malaguarnera G, Vacante M, Motta M.
    J Cancer Res Ther; 2011; 7(2):115-9. PubMed ID: 21768695
    [Abstract] [Full Text] [Related]

  • 29. Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer.
    Fedarko NS, Jain A, Karadag A, Van Eman MR, Fisher LW.
    Clin Cancer Res; 2001 Dec; 7(12):4060-6. PubMed ID: 11751502
    [Abstract] [Full Text] [Related]

  • 30. Over-expression of bone sialoprotein enhances bone metastasis of human breast cancer cells in a mouse model.
    Zhang JH, Tang J, Wang J, Ma W, Zheng W, Yoneda T, Chen J.
    Int J Oncol; 2003 Oct; 23(4):1043-8. PubMed ID: 12963984
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Prognostic factors for skeletal relapse in breast cancer.
    Diel IJ.
    Cancer Treat Rev; 2001 Jun; 27(3):153-7; discussion 159-64. PubMed ID: 11417965
    [Abstract] [Full Text] [Related]

  • 36. Bone sialoprotein stimulates focal adhesion-related signaling pathways: role in migration and survival of breast and prostate cancer cells.
    Gordon JA, Sodek J, Hunter GK, Goldberg HA.
    J Cell Biochem; 2009 Aug 15; 107(6):1118-28. PubMed ID: 19492334
    [Abstract] [Full Text] [Related]

  • 37. Serum levels of hepatocyte growth factor in patients with breast cancer.
    Sheen-Chen SM, Liu YW, Eng HL, Chou FF.
    Cancer Epidemiol Biomarkers Prev; 2005 Mar 15; 14(3):715-7. PubMed ID: 15767355
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Prognostic role of serum cancer antigen 15-3 in breast cancer patients with isolated bone metastases.
    Turanli S, Cetin A.
    Biomarkers; 2010 Aug 15; 15(5):418-23. PubMed ID: 20441435
    [Abstract] [Full Text] [Related]

  • 40. Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424).
    Harbeck N, Kates RE, Look MP, Meijer-Van Gelder ME, Klijn JG, Krüger A, Kiechle M, Jänicke F, Schmitt M, Foekens JA.
    Cancer Res; 2002 Aug 15; 62(16):4617-22. PubMed ID: 12183417
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.